PMID- 38340956 OWN - NLM STAT- MEDLINE DCOM- 20240226 LR - 20240226 IS - 1873-7064 (Electronic) IS - 0028-3908 (Linking) VI - 247 DP - 2024 Apr 1 TI - Impact of caloric restriction on oxidative stress and key glycolytic enzymes in the cerebral cortex, liver and kidney of old and middle-aged mice. PG - 109859 LID - S0028-3908(24)00025-X [pii] LID - 10.1016/j.neuropharm.2024.109859 [doi] AB - Caloric restriction (CR) is proposed as a strategy to prevent age-related alterations like impaired glucose metabolism and intensification of oxidative stress. In this study, we examined effects of aging and CR on the activities of glycolytic enzymes and parameters of oxidative stress in the cerebral cortex, liver, and kidney of middle-aged (9 months old) and old (18 months old) C57BL6/N mice. Control middle-aged and old mice were fed ad libitum (AL groups), whereas age-matched CR groups were subjected to CR (70% of individual ad libitum food intake) for 6 and 12 months, respectively. There were no significant differences in the activities of key glycolytic and antioxidant enzymes and oxidative stress indices between the cortices of middle-aged and old AL mice. The livers and kidneys of old AL mice showed higher activity of glucose-6-phosphate dehydrogenase, an enzyme that produces NADPH in the pentose phosphate pathway, compared to those of middle-aged mice. CR regimen modulated some biochemical parameters in middle-aged but not in old mice. In particular, CR decreased oxidative stress intensity in the liver and kidney but had no effects on those parameters in the cerebral cortex. In the liver, CR led to lower activities of glycolytic enzymes, whereas its effect was the opposite in the kidney. The results suggest that during physiological aging there is no significant intensification of oxidative stress and glycolysis decline in mouse tissues during the transition from middle to old age. The CR regimen has tissue-specific effects and improves the metabolic state of middle-aged mice. This article is part of the Special Issue on "Ukrainian Neuroscience". CI - Copyright (c) 2024. Published by Elsevier Ltd. FAU - Vatashchuk, Myroslava V AU - Vatashchuk MV AD - Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine. FAU - Hurza, Viktoriia V AU - Hurza VV AD - Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine. FAU - Stefanyshyn, Nadiia AU - Stefanyshyn N AD - Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine. FAU - Bayliak, Maria M AU - Bayliak MM AD - Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine. FAU - Gospodaryov, Dmytro V AU - Gospodaryov DV AD - Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine. FAU - Garaschuk, Olga AU - Garaschuk O AD - Department of Neurophysiology, University of Tubingen, Tubingen, 72074, Germany. Electronic address: olga.garaschuk@uni-tuebingen.de. FAU - Lushchak, Volodymyr I AU - Lushchak VI AD - Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine; Research and Development University, 13a Shota Rustaveli Str., Ivano-Frankivsk, 76018, Ukraine. Electronic address: volodymyr.lushchak@pnu.edu.ua. LA - eng PT - Journal Article DEP - 20240209 PL - England TA - Neuropharmacology JT - Neuropharmacology JID - 0236217 SB - IM MH - Mice MH - Animals MH - *Caloric Restriction/methods MH - *Oxidative Stress/physiology MH - Aging/metabolism MH - Liver/metabolism MH - Kidney MH - Glycolysis MH - Cerebral Cortex OTO - NOTNLM OT - Aging OT - Antioxidant system OT - Caloric restriction OT - Cerebral cortex OT - Glycolysis OT - Mice COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2024/02/11 07:42 MHDA- 2024/02/26 06:44 CRDT- 2024/02/10 19:15 PHST- 2023/10/15 00:00 [received] PHST- 2023/12/28 00:00 [revised] PHST- 2024/01/25 00:00 [accepted] PHST- 2024/02/26 06:44 [medline] PHST- 2024/02/11 07:42 [pubmed] PHST- 2024/02/10 19:15 [entrez] AID - S0028-3908(24)00025-X [pii] AID - 10.1016/j.neuropharm.2024.109859 [doi] PST - ppublish SO - Neuropharmacology. 2024 Apr 1;247:109859. doi: 10.1016/j.neuropharm.2024.109859. Epub 2024 Feb 9.